Clinical Trials

360 enrolled

Phase 2 Active not recruiting

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant

NCT07047118 2026-04-08

A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

134 enrolled

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT06353386 2026-03-24

MK-5684-01A

220 enrolled

Phase 2 Active not recruiting

Prostatic Neoplasms, Castration-Resistant

NCT05848011 2026-03-16

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

154 enrolled

Prostatic Neoplasms, Castration-Resistant

NCT07258407 2026-03-16

A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer

180 enrolled

Prostatic Neoplasms, Castration-Resistant

NCT05968599 2026-02-25

A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

Completed

2,731 enrolled 14 charts

Phase 4 Active not recruiting

Prostatic Neoplasms, Castration-Resistant

NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

100 enrolled

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

NCT05997615 2026-02-24

AMX-500

390 enrolled

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05551117 2026-02-09

Tamarack

Phase 2 Terminated

192 enrolled 20 charts

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Carcinoma, Small Cell, Small Cell Lung Carcinoma, Prostatic Neoplasms, Castration-Resistant

NCT04868604 2026-02-05

SECuRE

54 enrolled

Prostatic Neoplasms, Castration-Resistant

NCT06242470 2026-02-05

A Study of MGC026 in Participants With Advanced Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

250 enrolled

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma, Prostatic Neoplasms, Castration-Resistant

NCT06067841 2026-02-04

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

140 enrolled

Neoplasms, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT07376057 2026-01-29

Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer

Not yet recruiting

150 enrolled

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05519449 2026-01-20

ENGAGER-PSMA-01

272 enrolled